SCHEMBL6695228

SCHEMBL6695228

O=Nc1c(O)c2ccccc2oc1=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.59
▸ ALDH1A1 P00352 6/20 0.57
▸ NQO1 P15559 5/20 0.57
▸ MEN1 O00255 1/20 0.57
▸ ABCB11 O95342 1/20 0.57
▸ LMNA P02545 1/20 0.57
▸ TP53 P04637 1/20 0.57
▸ CYP1A2 P05177 1/20 0.57
▸ CYP3A4 P08684 1/20 0.57
▸ CYP2C9 P11712 1/20 0.57
▸ TSHR P16473 1/20 0.57
▸ MAPK1 P28482 1/20 0.57
▸ CYP2C19 P33261 1/20 0.57
▸ KMT2A Q03164 1/20 0.57
▸ PDE4D Q08499 1/20 0.57
▸ PCSK7 Q16549 1/20 0.57
▸ GPR35 Q9HC97 1/20 0.57
▸ CA12 O43570 1/20 0.54
▸ CA9 Q16790 1/20 0.54
▸ MAPT P10636 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11766670 0.80 MAPT (0.59) KDM4EALDH1A1NQO1MEN1ABCB11
SCHEMBL11766676 0.80 MAPT (0.59) KDM4EALDH1A1NQO1MEN1ABCB11
SCHEMBL29950209 0.80 KDM4E (0.53) KDM4EALDH1A1NQO1MEN1ABCB11
SCHEMBL15541690 0.80 KDM4E (0.53) KDM4EALDH1A1NQO1MEN1ABCB11
SCHEMBL7737431 0.79 KDM4E (0.69) KDM4EALDH1A1NQO1MEN1ABCB11
SCHEMBL29379994 0.79 KDM4E (0.69) KDM4EALDH1A1NQO1MEN1ABCB11
SCHEMBL29872 0.79 KDM4E (0.69) KDM4EALDH1A1NQO1MEN1ABCB11
SCHEMBL28282771 0.78 KDM4E (0.62) KDM4EALDH1A1NQO1MEN1ABCB11
Hydrochloric Acid SCHEMBL8701572 0.77 KDM4E (0.67) KDM4EALDH1A1NQO1MEN1ABCB11
SCHEMBL5713261 0.76 KDM4E (0.65) KDM4EALDH1A1NQO1MEN1ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040049859-A1 Enzyme composition for bleaching human keratinous fibres and bleaching method L'OREAL S.A. (FR) 2004-03-18 — — US claimed
US-20040040098-A1 Compositions for the oxidation dyeing of keratin fibers and dyeing processes using these compositions L'OREAL 2004-03-04 — — US claimed
US-20040025265-A1 Enzyme composition for bleaching human keratinous fibres and bleaching method LANG GERARD (FR) 2004-02-12 — — US claimed
US-20030159706-A1 Enzyme composition for bleaching human keratinous fibres and bleaching method L'OREAL S.A. (FR) 2003-08-28 — — US claimed
US-20040049859-A1 Enzyme composition for bleaching human keratinous fibres and bleaching method L'OREAL S.A. (FR) 2004-03-18 — — US disclosed
US-20040040098-A1 Compositions for the oxidation dyeing of keratin fibers and dyeing processes using these compositions L'OREAL 2004-03-04 — — US disclosed
US-20040025265-A1 Enzyme composition for bleaching human keratinous fibres and bleaching method LANG GERARD (FR) 2004-02-12 — — US disclosed
US-20040016062-A1 Nondyeing composition containing a precursor and an oxidation reaction catalyst L'OREAL (FR) 2004-01-29 — — US disclosed
EP-1367983-A1 MICROCAPSULES WITH AQUEOUS CORE CONTAINING OXIDATION-REDUCTION ENZYMES AND THEIR USE IN OXIDATION DYEING COMPOSITIONS L'OREAL (FR) 2003-12-10 — — EP disclosed
US-20030159706-A1 Enzyme composition for bleaching human keratinous fibres and bleaching method L'OREAL S.A. (FR) 2003-08-28 — — US disclosed
EP-1304997-A1 ENZYME COMPOSITION FOR BLEACHING HUMAN KERATINOUS FIBRES AND BLEACHING METHOD L'OREAL (FR) 2003-05-02 — — EP disclosed
EP-1304998-A1 ENZYME COMPOSITION FOR BLEACHING HUMAN KERATINOUS FIBRES AND BLEACHING METHOD L'OREAL (FR) 2003-05-02 — — EP disclosed
EP-1304996-A1 ENZYME COMPOSITION FOR BLEACHING HUMAN KERATINOUS FIBRES AND BLEACHING METHOD L'OREAL (FR) 2003-05-02 — — EP disclosed
WO-2002069922-A1 MICROCAPSULES WITH AQUEOUS CORE CONTAINING OXIDATION-REDUCTION ENZYMES AND THEIR USE IN OXIDATION DYEING COMPOSITIONS L'OREAL (FR) 2002-09-12 — — WO disclosed
WO-2002007689-A1 ENZYME COMPOSITION FOR BLEACHING HUMAN KERATINOUS FIBRES AND BLEACHING METHOD L'OREAL (FR) 2002-01-31 — — WO disclosed
WO-2002007688-A1 ENZYME COMPOSITION FOR BLEACHING HUMAN KERATINOUS FIBRES AND BLEACHING METHOD L'OREAL (FR) 2002-01-31 — — WO disclosed
WO-2002007687-A1 ENZYME COMPOSITION FOR BLEACHING HUMAN KERATINOUS FIBRES AND BLEACHING METHOD L'OREAL (FR) 2002-01-31 — — WO disclosed
EP-0843723-A1 METHOD FOR ENHANCING THE ACTIVITY OF AN ENZYME, COMPOUNDS SHOWING ENZYME ACTIVITY ENHANCEMENT, AND DETERGENTS CONTAINING SUCH COMPOUNDS Ciba SC Holding AG (CH) 1998-05-27 — — EP disclosed
WO-1997006244-A1 METHOD FOR ENHANCING THE ACTIVITY OF AN ENZYME, COMPOUNDS SHOWING ENZYME ACTIVITY ENHANCEMENT, AND DETERGENTS CONTAINING SUCH COMPOUNDS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 1997-02-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030159706-A1 Enzyme composition for bleaching human keratinous fibres and bleaching method KRT18, LPO, MPO KDM4E 354/4885ALDH1A1 347/4885NQO1 326/4885
US-20040025265-A1 Enzyme composition for bleaching human keratinous fibres and bleaching method KRT18, LPO, ALDH1A2 KDM4E 498/4885ALDH1A1 494/4885NQO1 403/4885
US-20040049859-A1 Enzyme composition for bleaching human keratinous fibres and bleaching method KRT18, COXFA4, LPO KDM4E 403/4885ALDH1A1 322/4885NQO1 452/4885
US-20040040098-A1 Compositions for the oxidation dyeing of keratin fibers and dyeing processes using these compositions KRT18, PPOX, POR KDM4E 766/4885ALDH1A1 164/4885NQO1 34/4885
US-20040016062-A1 Nondyeing composition containing a precursor and an oxidation reaction catalyst KRT18, CUTA, PPOX KDM4E 848/4885ALDH1A1 1106/4885NQO1 71/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback